Discover why Denali Therapeutics Inc. earns a Strong Buy with FDA-priority drugs, solid pipeline, and a strong cash position.

Fintel reports that on December 11, 2025, Wedbush maintained coverage of Denali Therapeutics (NasdaqGS:DNLI) with a ...

As Holland America Line prepares to celebrate 80 years of exploring Alaska, the cruise line is unveiling its 2027 Cruisetour ...

in this video we will review this Candy Orange gmc Yukon Denali on 30” dub Floaters Trump pardoned them for Jan. 6. Now they ...

This is about respecting the original stewards of the land who gave this fitting name,” she said. To pass her bill, other ...

Denali has entered a $275m royalty funding agreement with Royalty Pharma based on future net sales of tividenofusp alfa ...

Hypersensitivity reactions in a mouse model prompted the agency to suspend Denali’s planned Phase I development for DNL952 ...

Denali's validated platform, strategic pipeline, and experienced management present a compelling long-term investment opportunity. Find out why DNLI stock is a Buy.

Alaska's senior senator is again trying to move mountains to get the White House to restore Denali as the official name of ...

The FDA has placed a hold on Denali Therapeutics’ plans to launch a phase 1 rare disease trial, citing concerns about immune ...

Denali Therapeutics shares were lower in premarket trading Wednesday after it priced its share offering below current trading levels. Shares were down 9.7% ahead of the morning bell at $17.75. The ...

Denali Therapeutics filed a Registration Statement on Form S-3, which was automatically effective upon filing with the SEC on February 27, 2025, and has filed a preliminary prospectus supplement and ...